文献

J-GLOBAL ID：202202256783590625   整理番号：22A0843363

2型糖尿病患者の心血管疾患の10年リスクに対するサルコペニアとAnemiaの相加効果【JST・京大機械翻訳】

Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes

著者 (32件)： Zeng Feihui (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zeng Feihui (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zeng Feihui (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zeng Feihui (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Huang Lingning (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Huang Lingning (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Huang Lingning (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Huang Lingning (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhang Yongze (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhang Yongze (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhang Yongze (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhang Yongze (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Hong Xinyu (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Hong Xinyu (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Hong Xinyu (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Hong Xinyu (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Weng Suiyan (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Weng Suiyan (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Weng Suiyan (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Weng Suiyan (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Shen Ximei (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Shen Ximei (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Shen Ximei (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Shen Ximei (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhao Fengying (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhao Fengying (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhao Fengying (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Zhao Fengying (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Yan Sunjie (Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Yan Sunjie (Clinical Research Center for Metabolic Diseases of Fujian Province, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Yan Sunjie (Diabetes Research Institute of Fujian Province, The First Affiliated Hospital, Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China) ,  Yan Sunjie (Metabolic Diseases Research Institute, The First Affiliated Hospital of Fujian Medical University, 20 Cha Zhong Road, Fuzhou, Fujian 350005, China)
資料名： Journal of Diabetes Research (Web)  (Journal of Diabetes Research (Web))
巻： 2022  ページ： Null  発行年： 2022年 
JST資料番号： U7765A  ISSN： 2314-6745  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： 目的.目的:糖尿病患者におけるサルコペニアと貧血と10年心血管疾患リスクの間の関係を検討した。【方法】2型糖尿病の4673人の入院患者(男性2271人と女性2402人)を含む横断的研究を実施し,[数式:原文を参照]年の平均年齢は542人で,追跡期間中央値は24か月であった。すべての参加者は身体組成測定を受け,それらは10年間の心血管リスクを評価するためにFramininghamリスクモデルを用いてサルコペニアの性別と存在によってグループ分けされた。追跡調査中の心血管リスクの変化に従って,患者を4群に分けた:低低,高低,および高高。結果.貧血の有病率は非サルコペニア群よりサルコペニア群で高かった(11.5%対24.1%,[数式:原文を参照];13.9%対19.7%,女性,[数式:原文を参照])。サルコペニアと貧血のない患者は,高10年心血管疾患(CVD)([数式:原文を参照],95%信頼区間(CI)1.085~1.972,[数式:原文を参照])のリスク増加46.2%を有し,リスクは,サルコペニアと貧血の患者で([数式:原文を参照],95%CI2.038~5.289,[数式:原文を参照])より2倍高かった。追跡調査において,サルコペニアは10年でCVDのリスク増加と関連し,虫垂骨格筋量指数の減少はCVDのリスク増加を独立して予測した。結論:サルコペニアは貧血のリスク増加と関連し,両者の存在は2型糖尿病患者の10年CVDリスクに付加的効果を持つ。筋肉量の消失は糖尿病患者におけるCVDリスクの増加を独立して予測することができる。Copyright 2022 Feihui Zeng et al. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： *リスク ,  相加作用 ,  貧血 ,  女性 ,  年齢 ,  *心血管疾患 ,  罹患率 ,  虫垂 ,  *2型糖尿病 ,  追跡調査 ,  *サルコペニア
準シソーラス用語： 筋肉量 ,  骨格筋量 ,  心血管リスク ,  *糖尿病患者 , 【Automatic Indexing@JST】

分類 (2件)： 代謝異常・栄養性疾患一般  (GD05010J) ,  循環系の疾患  (GJ03000C)

引用文献 (50件)：

• E. Dent, J. E. Morley, A. J. Cruz-Jentoft, H. Arai, S. B. Kritchevsky, J. Guralnik, J. M. Bauer, M. Pahor, B. C. Clark, M. Cesari, J. Ruiz, C. C. Sieber, M. Aubertin-Leheudre, D. L. Waters, R. Visvanathan, F. Landi, D. T. Villareal, R. Fielding, C. W. Won, O. Theou, F. C. Martin, B. Dong, J. Woo, L. Flicker, L. Ferrucci, R. A. Merchant, L. Cao, T. Cederholm, S. M. L. Ribeiro, L. Rodríguez-Mañas, S. D. Anker, J. Lundy, L. M. Gutiérrez Robledo, I. Bautmans, I. Aprahamian, J. Schols, M. Izquierdo, B. Vellas, "International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management," The Journal of Nutrition, Health & Aging, vol. 22, no. 10, pp. 1148-1161, 2018.
• J. Pacifico, M. A. J. Geerlings, E. M. Reijnierse, C. Phassouliotis, W. K. Lim, A. B. Maier, "Prevalence of sarcopenia as a comorbid disease: A systematic review and meta- analysis," Experimental Gerontology, vol. 131, article 110801, 2020.
• T. N. Kim, M. S. Park, S. J. Yang, H. J. Yoo, H. J. Kang, W. Song, J. A. Seo, S. G. Kim, N. H. Kim, S. H. Baik, D. S. Choi, K. M. Choi, "Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)," Diabetes Care, vol. 33, pp. 1497-1499, 2010.
• H. Trierweiler, G. Kisielewicz, T. Hoffmann Jonasson, R. Rasmussen Petterle, C. Aguiar Moreira, V. Z. C. Borba, "Sarcopenia: a chronic complication of type 2 diabetes mellitus," Diabetology & Metabolic Syndrome, vol. 10, pp. 25, 2018.
• S. Ida, R. Kaneko, K. Imataka, K. Murata, "Association between sarcopenia and renal function in patients with diabetes: a systematic review and meta-analysis," Journal of Diabetes Research, vol. 2019, pp. 11, 2019.

タイトルに関連する用語 (6件)： 2型糖尿病 ,  患者 ,  心血管疾患 ,  リスク ,  サルコペニア ,  相加効果